Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Tommy G Thompson. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Tommy G Thompson har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:UTHR / United Therapeutics Corporation | Director | 8 480 |
US:421915EH8 / Health Care Ppty Investor 5.65% Notes 12/15/13 | Director | 144 290 |
US:TXMD / TherapeuticsMD, Inc. | Director | 14 779 |
US:DOC / Healthpeak Properties, Inc. | Director | 0 |
US:CNC / Centene Corporation | Director | 227 334 |
US:TYME / Tyme Technologies Inc | Director | 50 000 |
US:BCR / C. R. Bard, Inc. - Corporate Bond/Note | Director | 0 |
US:CYTX / Cytori Therapeutics, Inc. | Director | 136 950 |
US:US92942V2088 / VYANT BIO INC | Director | 10 000 |
US:CRVW / CareView Communications, Inc. | Director | 4 845 424 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Tommy G Thompson. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CRVW / CareView Communications, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CRVW / CareView Communications, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2013-04-01 | CRVW | Thompson Tommy G | 20 202 | 0,4950 | 20 202 | 0,4950 | 10 000 | 344 | 0.79 | 5 961 | 59,61 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CRVW / CareView Communications, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp PSTV / Plus Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CRVW / CareView Communications, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CRVW / CareView Communications, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp TXMD / TherapeuticsMD, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CRVW / CareView Communications, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CRVW / CareView Communications, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Tommy G Thompson som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −4 560 | 8 480 | −34,97 | 403,36 | −1 839 322 | 3 420 493 | |
2025-09-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 4 560 | 13 040 | 53,77 | 229,81 | 1 047 934 | 2 996 722 | |
2025-05-28 |
|
4 | DOC |
HEALTHPEAK PROPERTIES, INC.
Common Stock |
P - Purchase | 5 777 | 144 290 | 4,17 | 17,27 | 99 769 | 2 491 888 | |
2025-05-12 |
|
4 | DOC |
HEALTHPEAK PROPERTIES, INC.
Common Stock |
P - Purchase | 5 700 | 138 513 | 4,29 | 17,36 | 98 974 | 2 405 112 | |
2025-05-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 500 | 8 480 | −22,77 | 305,15 | −762 865 | 2 587 638 | |
2025-05-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 980 | 29,48 | 175,43 | 438 575 | 1 926 221 | |
2025-04-29 |
|
4 | DOC |
HEALTHPEAK PROPERTIES, INC.
Common Stock |
A - Award | 10 657 | 132 813 | 8,72 | ||||
2025-04-15 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 325 | 14 779 | 2,25 | 1,00 | 326 | 14 806 | |
2025-03-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 500 | 8 480 | −22,77 | 318,80 | −796 990 | 2 703 392 | |
2025-03-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 980 | 29,48 | 175,43 | 438 575 | 1 926 221 | |
2025-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 500 | 8 480 | −22,77 | 318,34 | −795 838 | 2 699 482 | |
2025-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 980 | 29,48 | 175,43 | 438 575 | 1 926 221 | |
2025-02-20 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
M - Exercise | 8 500 | 14 454 | 142,76 | ||||
2024-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −900 | 8 480 | −9,59 | 320,84 | −288 754 | 2 720 709 | |
2024-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −1 515 | 9 380 | −13,91 | 320,21 | −485 121 | 3 003 587 | |
2024-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −5 085 | 10 895 | −31,82 | 318,81 | −1 621 160 | 3 473 459 | |
2024-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 7 500 | 15 980 | 88,44 | 175,43 | 1 315 725 | 2 803 371 | |
2024-04-30 |
|
4 | DOC |
HEALTHPEAK PROPERTIES, INC.
Common Stock |
A - Award | 9 575 | 122 156 | 8,50 | ||||
2024-03-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −5 000 | 8 480 | −37,09 | 249,51 | −1 247 550 | 2 115 845 | |
2024-03-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 5 000 | 13 480 | 58,96 | 88,03 | 440 150 | 1 186 644 | |
2024-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 8 480 | −19,08 | 243,05 | −486 100 | 2 061 064 | |
2024-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 10 480 | 23,58 | 88,03 | 176 060 | 922 554 | |
2024-03-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 8 480 | −19,08 | 236,97 | −473 940 | 2 009 506 | |
2024-03-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 10 480 | 23,58 | 88,03 | 176 060 | 922 554 | |
2024-03-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 8 480 | −19,08 | 231,92 | −463 840 | 1 966 682 | |
2024-03-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 10 480 | 23,58 | 88,03 | 176 060 | 922 554 | |
2024-03-04 | 3 | DOC |
HEALTHPEAK PROPERTIES, INC.
Common Stock |
112 581 | ||||||||
2024-03-01 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
D - Sale to Issuer | −25 635 | 0 | −100,00 | ||||
2024-03-01 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
D - Sale to Issuer | −167 035 | 0 | −100,00 | ||||
2024-03-01 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 10 205 | 167 035 | 6,51 | ||||
2024-03-01 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 582 | 156 830 | 3,01 | ||||
2024-02-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 8 480 | −19,08 | 227,03 | −454 060 | 1 925 214 | |
2024-02-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 10 480 | 23,58 | 88,03 | 176 060 | 922 554 | |
2023-07-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 880 | 8 480 | 11,58 | ||||
2023-06-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 000 | 7 600 | −11,63 | 229,53 | −229 530 | 1 744 428 | |
2023-06-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 000 | 8 600 | 13,16 | 88,03 | 88 030 | 757 058 | |
2023-06-05 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 000 | 7 600 | −11,63 | 217,22 | −217 220 | 1 650 872 | |
2023-06-05 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 000 | 8 600 | 13,16 | 88,03 | 88 030 | 757 058 | |
2023-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 500 | 7 600 | −24,75 | 223,96 | −559 900 | 1 702 096 | |
2023-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 100 | 32,89 | 63,90 | 159 750 | 645 390 | |
2023-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 500 | 7 600 | −24,75 | 219,11 | −547 775 | 1 665 236 | |
2023-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 100 | 32,89 | 63,90 | 159 750 | 645 390 | |
2023-03-06 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 500 | 7 600 | −24,75 | 248,69 | −621 725 | 1 890 044 | |
2023-03-06 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 100 | 32,89 | 63,90 | 159 750 | 645 390 | |
2023-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 582 | 152 248 | 3,10 | ||||
2023-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 358 | 147 666 | 3,04 | ||||
2023-03-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 500 | 7 600 | −24,75 | 246,04 | −615 100 | 1 869 904 | |
2023-03-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 500 | 10 100 | 32,89 | 63,90 | 159 750 | 645 390 | |
2022-12-15 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 6 575 | 25 635 | 34,50 | 15,04 | 98 888 | 385 550 | |
2022-12-15 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 17 760 | 19 060 | 1 366,15 | 15,16 | 269 242 | 288 950 | |
2022-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −5 000 | 7 600 | −39,68 | 266,86 | −1 334 300 | 2 028 136 | |
2022-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 5 000 | 12 600 | 65,79 | 63,90 | 319 500 | 805 140 | |
2022-08-22 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
M - Exercise | 2 976 | 5 954 | 99,93 | ||||
2022-07-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 080 | 7 600 | 16,56 | ||||
2022-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −2 200 | 0 | −100,00 | ||||
2022-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 200 | 6 520 | −25,23 | 224,78 | −494 516 | 1 465 566 | |
2022-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 200 | 8 720 | 33,74 | 48,11 | 105 842 | 419 519 | |
2022-03-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 500 | 2 200 | −40,54 | ||||
2022-03-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 500 | 6 520 | −18,70 | 178,46 | −267 690 | 1 163 559 | |
2022-03-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 500 | 8 020 | 23,01 | 48,11 | 72 165 | 385 842 | |
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 509 | 3 700 | −28,97 | ||||
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 509 | 6 520 | −18,79 | 184,49 | −278 395 | 1 202 875 | |
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 509 | 8 029 | 23,14 | 48,11 | 72 598 | 386 275 | |
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 500 | 5 209 | −22,36 | ||||
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 500 | 6 520 | −18,70 | 182,55 | −273 825 | 1 190 226 | |
2022-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 500 | 8 020 | 23,01 | 48,11 | 72 165 | 385 842 | |
2022-03-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 500 | 6 709 | −18,27 | ||||
2022-03-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 500 | 6 520 | −18,70 | 178,82 | −268 230 | 1 165 906 | |
2022-03-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 500 | 8 020 | 23,01 | 48,11 | 72 165 | 385 842 | |
2022-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 000 | 8 209 | −10,86 | ||||
2022-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 000 | 6 520 | −13,30 | 167,78 | −167 780 | 1 093 926 | |
2022-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 000 | 7 520 | 15,34 | 48,11 | 48 110 | 361 787 | |
2022-03-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 500 | 9 209 | −14,01 | ||||
2022-03-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 500 | 6 520 | −18,70 | 174,96 | −262 440 | 1 140 739 | |
2022-03-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 500 | 8 020 | 23,01 | 48,11 | 72 165 | 385 842 | |
2022-03-03 |
|
4 | DOC |
Physicians Realty Trust
2020 Restricted Share Unit Grant |
M - Exercise | −3 886 | 0 | −100,00 | ||||
2022-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 3 886 | 138 432 | 2,89 | ||||
2022-03-03 |
|
4 | DOC |
Physicians Realty Trust
2022 Restricted Share Unit Grant |
A - Award | 9 164 | 9 164 | |||||
2022-03-03 |
|
4 | DOC |
Physicians Realty Trust
2021 Restricted Share Unit Grant |
M - Exercise | −4 358 | 4 358 | −50,00 | ||||
2022-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 358 | 134 546 | 3,35 | ||||
2022-01-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 450 | 227 334 | 0,20 | ||||
2021-10-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 524 | 226 884 | 0,23 | 66,82 | 35 000 | 15 160 389 | |
2021-08-17 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 11 000 | 715 600 | 1,56 | 0,87 | 9 570 | 622 572 | |
2021-08-12 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Restricted Stock Units |
M - Exercise | −145 296 | 0 | −100,00 | ||||
2021-08-12 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
M - Exercise | 145 296 | 148 851 | 4 087,09 | ||||
2021-07-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
A - Award | 1 080 | 1 080 | |||||
2021-07-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 3 230 | 3 230 | 183,98 | 594 255 | 594 255 | ||
2021-07-02 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Restricted Stock Units |
A - Award | 148 760 | 148 760 | |||||
2021-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 511 | 226 360 | 0,23 | 68,51 | 35 000 | 15 507 938 | |
2021-06-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
M - Exercise | −1 680 | 0 | −100,00 | ||||
2021-06-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 680 | 6 520 | 34,71 | ||||
2021-05-18 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 5 000 | 704 600 | 0,71 | 1,06 | 5 300 | 746 876 | |
2021-04-28 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 300 | 225 849 | 1,48 | 66,00 | 217 800 | 14 906 056 | |
2021-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 565 | 222 549 | 0,25 | 61,92 | 35 000 | 13 780 254 | |
2021-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −12 350 | 0 | −100,00 | ||||
2021-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −12 350 | 4 840 | −71,84 | 159,68 | −1 972 048 | 772 851 | |
2021-03-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 12 350 | 17 190 | 255,17 | 54,77 | 676 410 | 941 496 | |
2021-03-03 |
|
4 | DOC |
Physicians Realty Trust
2020 Restricted Share Unit Grant |
M - Exercise | −3 886 | 3 886 | −50,00 | ||||
2021-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 3 886 | 126 646 | 3,17 | ||||
2021-03-03 |
|
4 | DOC |
Physicians Realty Trust
2021 Restricted Share Unit Grant |
A - Award | 8 716 | 8 716 | |||||
2021-03-03 |
|
4 | DOC |
Physicians Realty Trust
2019 Restricted Share Unit Grant |
M - Exercise | −4 192 | 0 | −100,00 | ||||
2021-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 192 | 122 760 | 3,54 | ||||
2021-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 551 | 221 984 | 0,25 | 63,53 | 35 000 | 14 102 649 | |
2021-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
G - Gift | 60 000 | 60 000 | |||||
2021-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
G - Gift | −60 000 | 26 896 | −69,05 | ||||
2021-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
G - Gift | 74 000 | 74 000 | |||||
2021-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
G - Gift | −74 000 | 86 896 | −45,99 | ||||
2020-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −1 500 | 160 896 | −0,92 | 58,36 | −87 540 | 9 389 891 |
2020-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 563 | 221 433 | 0,26 | 62,12 | 35 000 | 13 755 428 | |
2020-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −1 500 | 162 396 | −0,92 | 64,13 | −96 195 | 10 414 455 |
2020-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 538 | 220 870 | 0,24 | 65,11 | 35 000 | 14 380 829 | |
2020-06-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 5 160 | 5 160 | |||||
2020-06-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
A - Award | 1 680 | 1 680 | |||||
2020-06-19 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Restricted Stock Units |
A - Award | 145 296 | 145 296 | |||||
2020-06-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −4 210 | 9 790 | −30,07 | 126,79 | −533 806 | 1 241 321 | |
2020-06-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 8 700 | 699 600 | 1,26 | 1,13 | 9 831 | 790 548 | |
2020-05-05 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −3 100 | 14 000 | −18,13 | 112,56 | −348 920 | 1 575 770 | |
2020-04-30 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 300 | 384 228 | 0,87 | 60,68 | 200 244 | 23 314 966 | |
2020-04-08 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −1 500 | 380 928 | −0,39 | 58,00 | −87 000 | 22 093 835 |
2020-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 577 | 382 428 | 0,15 | 60,68 | 35 000 | 23 205 742 | |
2020-03-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −500 | 381 851 | −0,13 | 53,42 | −26 710 | 20 398 501 |
2020-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −8 500 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −4 290 | 26 150 | −14,09 | 103,59 | −444 409 | 2 708 928 | |
2020-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 8 500 | 30 440 | 38,74 | 51,77 | 440 045 | 1 575 879 | |
2020-03-03 |
|
4 | DOC |
Physicians Realty Trust
2020 Restricted Share Unit Grant |
A - Award | 7 772 | 7 772 | |||||
2020-03-03 |
|
4 | DOC |
Physicians Realty Trust
2018 Restricted Share Unit Grant |
M - Exercise | −5 074 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 5 074 | 115 309 | 4,60 | ||||
2020-03-03 |
|
4 | DOC |
Physicians Realty Trust
2019 Restricted Share Unit Grant |
M - Exercise | −4 193 | 4 192 | −50,01 | ||||
2020-03-03 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 4 193 | 110 235 | 3,95 | ||||
2020-02-10 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −500 | 382 351 | −0,13 | 65,81 | −32 905 | 25 162 545 |
2020-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −500 | 382 851 | −0,13 | 62,98 | −31 490 | 24 111 980 |
2020-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 645 | 383 351 | 0,17 | 54,25 | 35 000 | 20 796 813 | |
2019-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 719 | 382 706 | 0,19 | 48,70 | 35 000 | 18 637 793 | |
2019-08-27 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 50 000 | 50 000 | |||||
2019-08-13 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 5 000 | 690 900 | 0,73 | 3,04 | 15 200 | 2 100 336 | |
2019-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 648 | 381 988 | 0,17 | 54,01 | 35 000 | 20 631 147 | |
2019-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
M - Exercise | −1 870 | 0 | −100,00 | ||||
2019-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 12 610 | 12 610 | |||||
2019-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 870 | 21 940 | 9,32 | ||||
2019-06-24 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 112 500 | 112 500 | |||||
2019-05-14 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 2 400 | 685 900 | 0,35 | 3,34 | 8 016 | 2 290 906 | |
2019-04-25 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 300 | 381 340 | 0,87 | 60,70 | 200 310 | 23 147 308 | |
2019-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 577 | 378 040 | 0,15 | 60,70 | 35 000 | 22 946 998 | |
2019-03-19 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −17 100 | 0 | −100,00 | ||||
2019-03-19 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 17 100 | 20 070 | 575,76 | 52,65 | 900 315 | 1 056 686 | |
2019-03-04 |
|
4 | DOC |
Physicians Realty Trust
2018 Restricted Share Unit Grant |
M - Exercise | −5 075 | 5 074 | −50,00 | ||||
2019-03-04 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
A - Award | 3 788 | 103 581 | 3,80 | 18,09 | 68 525 | 1 873 780 | |
2019-03-04 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
M - Exercise | 5 075 | 99 793 | 5,36 | 18,09 | 91 807 | 1 805 255 | |
2019-03-04 |
|
4 | DOC |
Physicians Realty Trust
2019 Restricted Share Unit Grant |
A - Award | 8 385 | 8 385 | |||||
2019-02-05 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −400 | 2 970 | −11,87 | 117,00 | −46 800 | 347 490 |
2019-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 261 | 188 731 | 0,14 | 133,89 | 35 000 | 25 269 254 | |
2018-12-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −900 | 17 100 | −5,00 | ||||
2018-12-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −900 | 3 370 | −21,08 | 111,00 | −99 900 | 374 070 | |
2018-12-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 900 | 4 270 | 26,71 | 52,65 | 47 385 | 224 816 | |
2018-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 252 | 188 470 | 0,13 | 138,85 | 35 000 | 26 169 066 | |
2018-08-28 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 50 000 | 50 000 | |||||
2018-08-23 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 4 000 | 683 500 | 0,59 | 5,52 | 22 100 | 3 776 338 | |
2018-07-05 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 75 000 | |||||
2018-07-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 303 | 188 218 | 0,16 | 115,33 | 35 000 | 21 707 180 | |
2018-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
M - Exercise | −1 620 | 0 | −100,00 | ||||
2018-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 620 | 3 370 | 92,57 | ||||
2018-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 4 620 | 4 620 | |||||
2018-06-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
A - Award | 1 870 | 1 870 | |||||
2018-05-29 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 75 000 | 75 000 | |||||
2018-05-10 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 1 300 | 1 300 | 15,22 | 19 786 | 19 786 | ||
2018-04-26 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 1 925 | 187 915 | 1,04 | 104,27 | 200 720 | 19 593 845 | |
2018-04-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 336 | 185 990 | 0,18 | 104,27 | 35 000 | 19 393 126 | |
2018-03-06 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 13 650 | 82 289 | 19,89 | 14,71 | 200 792 | 1 210 471 | |
2018-03-06 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
A - Award | 3 788 | 68 639 | 5,84 | 14,94 | 56 593 | 1 025 467 | |
2018-03-06 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
A - Award | 4 244 | 64 851 | 7,00 | 14,94 | 63 405 | 968 874 | |
2018-03-06 |
|
4 | DOC |
Physicians Realty Trust
2018 Restricted Share Unit Grant |
A - Award | 10 149 | 10 149 | |||||
2018-02-14 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
111 730 | ||||||||
2018-02-14 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
205 865 | ||||||||
2018-02-14 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
111 730 | ||||||||
2018-02-14 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
205 865 | ||||||||
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
D - Sale to Issuer | −8 541 | 0 | −100,00 | ||||
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
D - Sale to Issuer | −8 028 | 0 | −100,00 | ||||
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 38 | 8 028 | 0,47 | 331,24 | 12 471 | 2 659 347 | |
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −1 200 | 0 | −100,00 | ||||
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −1 200 | 0 | −100,00 | ||||
2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −6 293 | 0 | −100,00 | ||||
2018-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 361 | 185 654 | 0,19 | 96,88 | 35 000 | 17 986 144 | |
2017-12-18 |
|
4 | DOC |
Physicians Realty Trust
Common Shares, $0.01 par value |
P - Purchase | 2 705 | 49 339 | 5,80 | 18,46 | 49 934 | 910 798 | |
2017-12-11 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 5 000 | 679 500 | 0,74 | 6,21 | 31 050 | 4 219 695 | |
2017-12-05 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 245 | 8 541 | 2,95 | ||||
2017-12-05 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 298 | 6 293 | 4,97 | ||||
2017-12-05 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
G - Gift | −1 519 | 5 995 | −20,22 | ||||
2017-10-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 407 | 185 293 | 0,22 | 86,10 | 35 000 | 15 953 690 | |
2017-09-01 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 5 000 | 674 500 | 0,75 | 5,99 | 29 950 | 4 040 255 | |
2017-07-05 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 72 | 7 978 | 0,90 | 316,39 | 22 625 | 2 524 159 | |
2017-07-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 464 | 184 886 | 0,25 | 75,49 | 35 000 | 13 957 049 | |
2017-06-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 4 210 | 4 210 | |||||
2017-06-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
A - Award | 1 620 | 1 620 | |||||
2017-06-23 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 75 000 | |||||
2017-06-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −650 | 12 350 | −5,00 | ||||
2017-06-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
M - Exercise | −1 750 | 0 | −100,00 | ||||
2017-06-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −650 | 1 750 | −27,08 | 131,93 | −85 754 | 230 878 | |
2017-06-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 650 | 2 400 | 37,14 | 54,77 | 35 600 | 131 448 | |
2017-06-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 750 | 1 750 | |||||
2017-05-25 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −700 | 0 | −100,00 | ||||
2017-05-25 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −190 | 7 514 | −2,47 | 308,00 | −58 519 | 2 314 274 | |
2017-05-25 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 700 | 7 704 | 9,99 | 83,47 | 58 431 | 643 076 | |
2017-04-27 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 000 | 184 422 | 1,65 | 66,93 | 200 790 | 12 343 393 | |
2017-04-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 523 | 181 422 | 0,29 | 66,93 | 34 999 | 12 142 603 | |
2017-03-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −2 000 | 13 000 | −13,33 | ||||
2017-03-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 000 | 0 | −100,00 | 139,37 | −278 740 | ||
2017-03-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 2 000 | 54,77 | 109 540 | 109 540 | ||
2017-03-07 |
|
4 | DOC |
Physicians Realty Trust
Common Shares, $0.01 par value |
A - Award | 7 576 | 54 210 | 16,25 | ||||
2017-03-07 |
|
4/A | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 4 910 | 4 910 | |||||
2017-01-05 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 105 | 7 891 | 1,35 | 227,47 | 23 875 | 1 795 009 | |
2017-01-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 593 | 180 900 | 0,33 | 59,01 | 35 000 | 10 674 880 | |
2016-12-22 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2016-12-15 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 375 | 8 296 | 4,73 | ||||
2016-12-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 468 | 7 004 | 7,16 | ||||
2016-11-28 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 2 100 | 32 938 | 6,81 | 18,05 | 37 905 | 594 531 | |
2016-11-21 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 14 400 | 24 849 | 137,81 | 18,04 | 259 776 | 448 276 | |
2016-10-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 504 | 180 306 | 0,28 | 69,47 | 35 000 | 12 525 885 | |
2016-09-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 291 | 10 709 | −10,76 | ||||
2016-09-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −1 291 | 0 | −100,00 | 125,57 | −162 111 | ||
2016-09-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 291 | 1 291 | 48,11 | 62 110 | 62 110 | ||
2016-07-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 98 | 7 768 | 1,28 | 234,75 | 23 050 | 1 823 517 | |
2016-07-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 557 | 179 803 | 0,31 | 62,81 | 35 000 | 11 293 400 | |
2016-06-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Restricted Stock Units |
A - Award | 1 750 | 1 750 | |||||
2016-06-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 5 000 | 5 000 | |||||
2016-06-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −2 000 | 18 000 | −10,00 | ||||
2016-06-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 000 | 0 | −100,00 | 115,62 | −231 247 | ||
2016-06-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 2 000 | 52,65 | 105 300 | 105 300 | ||
2016-05-16 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −500 | 700 | −41,67 | ||||
2016-05-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −500 | 6 536 | −7,11 | 219,52 | −109 760 | 1 434 783 | |
2016-05-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 500 | 7 036 | 7,65 | 83,47 | 41 736 | 587 316 | |
2016-04-28 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 350 | 179 245 | 1,90 | 62,86 | 210 581 | 11 267 362 | |
2016-04-04 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 586 | 175 895 | 0,33 | 59,70 | 35 000 | 10 500 952 | |
2016-03-07 |
|
4 | DOC |
Physicians Realty Trust
2016 Time Based Restricted Share Unit Grant |
A - Award | 8 489 | 8 489 | |||||
2016-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −3 000 | 12 000 | −20,00 | ||||
2016-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −3 000 | 0 | −100,00 | 126,54 | −379 620 | ||
2016-03-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 3 000 | 3 000 | 48,11 | 144 330 | 144 330 | ||
2016-02-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −2 319 | 6 536 | −26,19 | 188,75 | −437 717 | 1 233 687 | |
2016-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 134 | 7 651 | 1,79 | 183,90 | 24 700 | 1 407 069 | |
2016-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 591 | 175 309 | 0,34 | 59,25 | 35 000 | 10 387 063 | |
2016-01-04 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Incentive Stock Option (Right to Buy) |
A - Award | 53 820 | 136 950 | 64,74 | ||||
2015-12-21 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 75 000 | |||||
2015-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 442 | 7 921 | 5,91 | ||||
2015-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 536 | 8 855 | 6,44 | ||||
2015-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 523 | 174 718 | 0,30 | 66,93 | 35 000 | 11 693 900 | |
2015-09-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −5 000 | 8 500 | −37,04 | ||||
2015-09-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −5 000 | 0 | −100,00 | 139,19 | −695 934 | ||
2015-09-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 5 000 | 5 000 | 51,77 | 258 850 | 258 850 | ||
2015-09-29 |
|
4/A | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 15 000 | 15 000 | |||||
2015-09-08 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Common Stock |
P - Purchase | 25 449 | 83 600 | 43,76 | 0,37 | 9 531 | 31 308 | |
2015-08-31 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 1 000 | 35 454 | 2,90 | 14,71 | 14 710 | 521 528 | |
2015-08-24 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 10 000 | 10 000 | 6,29 | 62 939 | 62 939 | ||
2015-08-24 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 343 | 1 000 | 52,21 | 6,29 | 2 159 | 6 294 | |
2015-08-24 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 455 | 1 000 | 83,49 | 6,29 | 2 864 | 6 294 | |
2015-08-17 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −1 200 | 0 | −100,00 | ||||
2015-08-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −1 200 | 8 319 | −12,61 | 199,25 | −239 103 | 1 657 585 | |
2015-08-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1 200 | 9 519 | 14,42 | 73,99 | 88 788 | 704 311 | |
2015-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 115 | 7 498 | 1,56 | 172,77 | 19 926 | 1 295 452 | |
2015-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 487 | 174 195 | 0,28 | 71,83 | 35 000 | 12 512 457 | |
2015-06-29 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 15 000 | 15 000 | |||||
2015-05-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −1 500 | 13 500 | −10,00 | ||||
2015-05-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −1 500 | 0 | −100,00 | 182,04 | −273 057 | ||
2015-05-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 500 | 1 500 | 51,77 | 77 655 | 77 655 | ||
2015-05-14 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Restricted Stock Award (Common Stock) |
A - Award | 42 785 | 42 785 | |||||
2015-05-12 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 3 000 | 3 555 | 540,54 | 6,09 | 18 270 | 21 650 | |
2015-05-12 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 3 000 | 3 555 | 540,54 | 6,09 | 18 270 | 21 650 | |
2015-04-29 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −1 200 | 0 | −100,00 | ||||
2015-04-29 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −1 200 | 8 319 | −12,61 | 170,43 | −204 515 | 1 417 800 | |
2015-04-29 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1 200 | 9 519 | 14,42 | 63,43 | 76 116 | 603 790 | |
2015-04-29 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 2 910 | 173 708 | 1,70 | 70,79 | 205 999 | 12 296 801 | |
2015-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 491 | 170 798 | 0,29 | 71,23 | 35 000 | 12 165 953 | |
2015-03-27 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-qualified stock option |
A - Award | 125 000 | 125 000 | |||||
2015-03-16 |
|
4 | CNC |
CENTENE CORP
Common Stock Option (right to buy) |
M - Exercise | −16 000 | 0 | −100,00 | 13,37 | −213 920 | ||
2015-03-16 |
|
4 | CNC |
CENTENE CORP
Common Stock |
S - Sale | X | −16 000 | 170 307 | −8,59 | 65,36 | −1 045 760 | 11 131 252 |
2015-03-16 |
|
4 | CNC |
CENTENE CORP
Common Stock |
M - Exercise | 16 000 | 186 307 | 9,39 | 13,37 | 213 920 | 2 490 922 | |
2015-03-10 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 650 | 34 604 | 1,91 | 16,08 | 10 452 | 556 432 | |
2015-03-10 |
|
4 | DOC |
Physicians Realty Trust
2015 Time Based Restricted Share Unit Grant |
A - Award | 9 451 | 9 451 | |||||
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
M - Exercise | −7 500 | 20 000 | −27,27 | ||||
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −200 | 0 | −100,00 | 154,84 | −30 968 | ||
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −2 300 | 200 | −92,00 | 154,80 | −356 040 | 30 960 | |
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −1 350 | 2 500 | −35,06 | 153,90 | −207 765 | 384 750 | |
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −3 650 | 3 850 | −48,67 | 152,73 | −557 464 | 588 010 | |
2015-02-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 7 500 | 7 500 | 52,65 | 394 875 | 394 875 | ||
2015-02-25 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Incentive Stock Option (Right to Buy) |
A - Award | 25 000 | 83 130 | 43,01 | ||||
2015-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 114 | 7 364 | 1,57 | 167,48 | 19 099 | 1 233 298 | |
2015-01-05 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 332 | 85 153 | 0,39 | 105,31 | 35 000 | 8 967 504 | |
2014-12-12 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 1 900 | 33 954 | 5,93 | 15,88 | 30 172 | 539 190 | |
2014-12-12 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 413 | 7 479 | 5,84 | ||||
2014-12-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 205 | 8 319 | 2,53 | ||||
2014-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 418 | 84 821 | 0,50 | 83,72 | 35 000 | 7 101 218 | |
2014-09-11 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-qualified stock option |
M - Exercise | 2 500 | 62 500 | 4,17 | ||||
2014-09-11 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
M - Exercise | 2 500 | 658 257 | 0,38 | 2,80 | 7 000 | 1 843 120 | |
2014-09-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 657 | 655 757 | 0,10 | 5,48 | 3 600 | 3 593 483 | |
2014-09-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 545 | 655 100 | 0,08 | 5,42 | 2 954 | 3 550 576 | |
2014-09-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 226 | 654 555 | 0,03 | 5,40 | 1 220 | 3 534 466 | |
2014-09-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 329 | 654 329 | 0,05 | 5,40 | 1 777 | 3 533 311 | |
2014-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 137 | 7 229 | 1,93 | 145,82 | 19 925 | 1 054 200 | |
2014-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 468 | 84 403 | 0,56 | 74,80 | 35 000 | 6 313 343 | |
2014-06-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 15 000 | 15 000 | |||||
2014-06-11 |
|
4 | [TXMD] |
TherapeuticsMD, Inc.
Non-qualified Stock Option |
M - Exercise | −10 000 | 65 000 | −13,33 | ||||
2014-06-11 |
|
4 | [TXMD] |
TherapeuticsMD, Inc.
Common Stock |
M - Exercise | 10 000 | 654 000 | 1,55 | 2,80 | 28 000 | 1 831 200 | |
2014-05-28 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
P - Purchase | 4 000 | 32 054 | 14,26 | 12,50 | 50 000 | 400 675 | |
2014-05-20 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Restricted Stock (Common Stock) |
A - Award | 5 501 | 16 051 | 52,14 | ||||
2014-05-09 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 14 000 | 644 000 | 2,22 | 3,57 | 50 039 | 2 301 785 | |
2014-05-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −400 | 0 | −100,00 | 107,16 | −42 864 | ||
2014-04-23 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 3 000 | 83 935 | 3,71 | 57,29 | 171 870 | 4 808 640 | |
2014-03-31 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 567 | 80 935 | 0,70 | 61,78 | 35 000 | 5 000 169 | |
2014-03-05 |
|
4 | DOC |
Physicians Realty Trust
Common shares, $0.01 par value |
A - Award | 6 311 | 28 054 | 29,03 | ||||
2014-01-08 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option |
A - Award | 70 000 | 620 000 | 12,73 | ||||
2014-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 157 | 7 071 | 2,28 | 131,83 | 20 750 | 932 175 | |
2014-01-03 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Non-Qualified Stock Option (Right to Buy) |
A - Award | 16 030 | 58 130 | 38,08 | ||||
2014-01-03 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Restricted Stock (Common Stock) |
A - Award | 10 550 | 10 550 | |||||
2014-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 602 | 80 369 | 0,76 | 58,11 | 35 000 | 4 670 216 | |
2013-12-17 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option |
A - Award | 250 000 | 550 000 | 83,33 | ||||
2013-12-17 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
P - Purchase | 30 000 | 630 000 | 5,00 | 1,70 | 51 000 | 1 071 000 | |
2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 512 | 7 066 | 7,81 | ||||
2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 367 | 8 114 | 4,74 | ||||
2013-10-15 |
|
4 | CGIX |
CANCER GENETICS, INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2013-10-15 |
|
4 | CGIX |
CANCER GENETICS, INC
Common Stock, par value $0.0001 per share |
A - Award | 2 500 | 2 500 | |||||
2013-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 542 | 79 766 | 0,68 | 64,63 | 35 000 | 5 155 292 | |
2013-09-03 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Common Stock |
P - Purchase | 5 000 | 39 050 | 14,68 | 2,14 | 10 700 | 83 567 | |
2013-08-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | −1 000 | 400 | −71,43 | 76,02 | −76 020 | 30 408 | |
2013-07-26 |
|
4 | DOC |
Physicians Realty Trust
Common shares of beneficial interest, $0.01 par value per sh |
A - Award | 8 696 | 21 743 | 66,65 | ||||
2013-07-26 |
|
4 | DOC |
Physicians Realty Trust
Common shares of beneficial interest, $0.01 par value per sh |
P - Purchase | 13 047 | 13 047 | 11,50 | 150 040 | 150 040 | ||
2013-07-19 | 3 | DOC |
Physicians Realty Trust
Common shares of beneficial interest, $0.01 par value per sh |
0 | ||||||||
2013-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 177 | 6 891 | 2,63 | 108,17 | 19 100 | 745 346 | |
2013-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 667 | 79 225 | 0,85 | 52,46 | 35 000 | 4 156 128 | |
2013-06-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 15 000 | 15 000 | |||||
2013-05-03 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualified Stock Option |
A - Award | 150 000 | 300 000 | 100,00 | ||||
2013-05-03 |
|
4 | TXMD |
TherapeuticsMD, Inc.
Non-Qualfied Stock Option |
A - Award | 75 000 | 150 000 | 100,00 | ||||
2013-04-24 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 4 000 | 78 558 | 5,36 | 45,35 | 181 400 | 3 562 584 | |
2013-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 795 | 74 558 | 1,08 | 44,04 | 35 000 | 3 283 513 | |
2013-04-01 |
|
4 | CRVW |
CareView Communications Inc
Common Stock |
P - Purchase | 20 202 | 4 845 424 | 0,42 | 0,50 | 10 000 | 2 398 485 | |
2013-02-21 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −200 | 7 747 | −2,52 | 100,25 | −20 050 | 776 629 | |
2013-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 236 | 6 688 | 3,66 | 101,83 | 24 050 | 681 005 | |
2013-01-03 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Non-Qualified Stock Option (Right to Buy) |
A - Award | 6 100 | 42 100 | 16,94 | ||||
2013-01-03 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Restricted Stock Award (Common Stock) |
A - Award | 6 100 | 6 100 | |||||
2013-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 889 | 73 763 | 1,22 | 39,35 | 35 000 | 2 902 566 | |
2012-12-26 |
|
4 | CRVW |
CareView Communications Inc
Common Stock |
J - Other | 3 500 000 | 3 500 000 | |||||
2012-12-26 |
|
4 | CRVW |
CareView Communications Inc
Common Stock |
J - Other | −3 500 000 | 1 325 222 | −72,54 | ||||
2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 715 | 6 554 | 12,25 | ||||
2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 584 | 7 947 | 7,93 | ||||
2012-10-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 1 200 | 7 363 | 19,47 | ||||
2012-10-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 936 | 72 873 | 1,30 | 37,41 | 35 000 | 2 726 191 | |
2012-07-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 370 | 6 425 | 6,10 | 107,83 | 39 850 | 692 798 | |
2012-07-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 1 160 | 71 938 | 1,64 | 30,16 | 35 000 | 2 169 643 | |
2012-06-27 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 15 000 | 15 000 | |||||
2012-06-12 |
|
4 | CNC |
CENTENE CORP
Common Stock Option (right to buy) |
M - Exercise | −2 000 | 8 000 | −20,00 | 26,75 | −53 500 | 214 000 | |
2012-06-12 |
|
4 | CNC |
CENTENE CORP
Common Stock |
M - Exercise | 2 000 | 70 777 | 2,91 | 26,75 | 53 500 | 1 893 292 | |
2012-05-17 | 3 | TXMD |
TherapeuticsMD, Inc.
Common Stock |
600 000 | ||||||||
2012-04-25 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 4 000 | 68 777 | 6,18 | 44,86 | 179 440 | 3 085 349 | |
2012-04-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 715 | 64 777 | 1,12 | 48,97 | 35 000 | 3 172 143 | |
2012-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 289 | 6 032 | 5,04 | 86,37 | 25 000 | 520 961 | |
2012-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 135 | 5 742 | 2,41 | 85,50 | 11 550 | 490 966 | |
2012-01-04 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Non-Qualified Stock Option (Right to Buy) |
A - Award | 15 000 | 36 000 | 71,43 | ||||
2012-01-04 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Restricted Stock Award |
A - Award | 10 000 | 34 050 | 41,58 | ||||
2012-01-03 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 884 | 64 063 | 1,40 | 39,59 | 35 000 | 2 536 237 | |
2011-08-23 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Common Stock |
P - Purchase | 2 164 | 24 050 | 9,89 | 3,25 | 7 033 | 78 162 | |
2011-08-23 |
|
4 | CYTX |
CYTORI THERAPEUTICS, INC.
Common Stock |
P - Purchase | 886 | 21 886 | 4,22 | 3,26 | 2 888 | 71 348 | |
2011-06-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 15 000 | 15 000 | |||||
2010-07-01 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 128 | 4 402 | 2,99 | 77,53 | 9 900 | 341 317 | |
2009-07-02 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 1 719 | 42 913 | 4,17 | 20,36 | 35 000 | 873 712 | |
2008-04-01 |
|
4 | CNC |
CENTENE CORP
Common Stock |
A - Award | 1 858 | 21 721 | 9,35 | 14,13 | 26 250 | 306 915 | |
2005-08-18 | 3/A | BCR |
BARD C R INC /NJ/
Common Stock |
0 |